Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Maraganore headlines Arch’s latest crop of venture partners 

Plus Five FDA vets join Sidley and updates from AZ, Neurocrine, ADCendo, Ironwood and more

December 2, 2021 2:46 AM UTC

John Maraganore, the outgoing CEO of Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), has joined Arch Venture Partners along with Jake Bauer, Axel Bouchon and Sabah Oney. Bauer and Oney both held CBO roles in their most recent posts, Bauer at MyoKardia Inc. and Oney at Alector Inc. (NASDAQ:ALEC). Bouchon, who is co-founder and chairman of BrainLuxury Inc. and co-founder and CEO of BrainGames Corp., previously led venture activities for Leaps by Bayer and Moderna Therapeutics Inc. (NASDAQ:MRNA). 

The firm also officially announced the addition of Luciana Borio, a veteran of FDA and the National Security Council who is advising Arch on and helping develop new investment opportunities related to manufacturing, clinical trials, novel therapies and areas with large unmet clinical needs, and the promotion of Carol Suh to partner from principal. The moves related to Borio and Suh became public in July...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article